{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-115955","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2024-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.739175+00:00","generated_at":"2026-05-30T12:24:06.621519+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Revelation Biosciences receives Nasdaq deficiency notices for bid price and stockholders' equity; intends to appeal","bullets":["Nasdaq notified REVB of non-compliance with $1.00 minimum bid price rule as of October 16, 2024.","Company not eligible for 180-day cure period due to reverse stock splits exceeding 250:1 cumulative ratio over two years.","Also cited for stockholders' equity deficiency (rule 5550(b)(1)), but company believes it satisfied requirement as of Sept 30, 2024 via Q3 financing.","Company will request a hearing before Nasdaq hearings panel to stay any suspension or delisting pending appeal.","Trading of common stock (REVB) and warrants (REVBW) continues on Nasdaq Capital Market for now."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-115955","json":"https://secwatch.observer/filing/0000950170-24-115955.json","markdown":"https://secwatch.observer/filing/0000950170-24-115955.md","text":"https://secwatch.observer/filing/0000950170-24-115955.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024115955/0000950170-24-115955-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017024115955/revb-20241016.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:24:06.621519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}